Fig. 2: NVP-BEZ235 inhibits HCC cell proliferation in a dose- and time-dependent manner.
From: The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma
A The proliferation rate of HepG2 cells treated with NVP-BEZ235. B The proliferation rate of Huh-7 cells treated with NVP-BEZ235. Compared to the 12 h treatment group. ns ≥ 0.05, * P < 0.05, ** P < 0.01, * P < 0.001.
